|
Historical Versions
|
ITMCTR2000002963
|
Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial |
Zhejiang Chinese Medical University |
Interventional study |
2020/02/03
|
|
Historical Versions
|
ITMCTR2000002962
|
Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial |
1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine |
Interventional study |
2020/02/02
|
|
Historical Versions
|
ITMCTR2000002961
|
Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia (COVID-19) in the Community Population |
Hospital of Chengdu University of Traditional Chinese Medicine |
Interventional study |
2020/02/02
|
|
Historical Versions
|
ITMCTR2000002960
|
Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19) |
The First Affiliated Hospital of He'nan University of Chinese Medicine |
Observational study |
2020/02/02
|
|
Historical Versions
|
ITMCTR2000002959
|
A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19) |
1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine |
Interventional study |
2020/02/02
|
|
Historical Versions
|
ITMCTR2000002958
|
The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period |
1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine |
Interventional study |
2020/02/02
|
|
Historical Versions
|
ITMCTR2000002957
|
A multi-center randomized controlled trial of Liu Jiaxiang Qi-Yin Recipe for improving the prognosis of patients with stage IIIA non-small cell lung cancer after radical resection |
Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine |
Interventional study |
2020/02/02
|
|
Historical Versions
|
ITMCTR2000002956
|
Study for TCM syndrome of PCOS infertility women with phlegm-dampness syndrome based on protemics of follicle fluid |
Affiliated Hospital of Shandong University of Traditional Chinese Medicine |
Interventional study |
2020/02/02
|
|
Historical Versions
|
ITMCTR2000002955
|
Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19) |
Tianjin University of Traditional Chinese Medicine |
Interventional study |
2020/02/01
|
|
Historical Versions
|
ITMCTR2000002954
|
A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19) |
Tianjin University of Traditional Chinese Medicine |
Interventional study |
2020/02/01
|
|
Historical Versions
|
ITMCTR2000002953
|
A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19) |
TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE |
Observational study |
2020/02/01
|
|
Historical Versions
|
ITMCTR2000002952
|
A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) |
The First Hospital of He'nan University of Chinese Medicine |
Interventional study |
2020/02/01
|
|
Historical Versions
|
ITMCTR2000002951
|
Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population |
Wuhan 1st Hospital |
Interventional study |
2020/02/01
|
|
Historical Versions
|
ITMCTR2000002950
|
A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule in the treatment of novel coronavirus pneumonia (COVID-19) |
Shijiazhuang Yiling Pharmaceutical Co., Ltd. |
Interventional study |
2020/02/01
|
|
Historical Versions
|
ITMCTR2000002949
|
A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19) |
Shijiazhuang Yiling Pharmaceutical Co., Ltd. |
Interventional study |
2020/02/01
|
